News and Announcements
DocDoc announce strategic investment from Cyberport Macro Fund with opening of Hong Kong office
- Published March 12, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Highlights
- DocDoc has announced an expansion into Hong Kong securing their latest investment from Cyberport Macro Fund (CMF).
- DocDoc will expand its market presence in Hong Kong with a new office opening in Hong Kong’s digital community hub, Cyberport.
- The latest investment from CMF brings DocDoc’s total funding to date to US$18.5 million.
DocDoc has announced an expansion into Hong Kong securing their latest investment from Cyberport Macro Fund (CMF) and the opening of a new office in Hong Kong’s Cyberport. Cyberport has rapidly accelerated the growth of Hong Kong’s technology community with the establishment of an innovative digital community hub. It has cemented itself as a key economic driver for Hong Kong.
DocDoc operates in 8 countries worldwide with more than 23 000 doctors utilising the platform. It is Asia’s leading patient empowerment company enabling patients to find the right care at the right time. DocDoc combines expertise in clinical informatics, artificial intelligence, and healthcare quality assessment to deliver simple patient solutions worldwide.
Through investment from CMF, DocDoc will expand its market presence in Hong Kong, strengthening its network of doctors within the region. It also opens up DocDoc to insurance companies as a value-added service, bringing new innovation and momentum to Hong Kong and Asia insurance markets.
The latest investment from CMF brings DocDoc’s total funding to date to US$18.5 million.
About DocDoc
DocDoc is Asia’s leading health insurance technology company. We provide data-enabled value-added services to insurance companies for their policyholders. Our services, spanning more than 23,000 doctors in eight countries, vastly improve the policyholders’ experience in consuming healthcare. DocDoc’s AI-powered doctor discovery, telemedicine and cashless services enable insurance companies to offer a differentiated product in a crowded market.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
